Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.
The American Society of Clinical Oncolgy (ASCO) is an international network of oncology professionals. The ASCO annual meeting offers premier scientific events for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide.
Caring for Every Patient, Learning from Every Patient
May 31 – June 4, 2019
Highlights included oral presentations on:
Other highlights included poster presentations on topics such as complications of bone marrow transplantation, quality of life in survivors of young-adult cancers, first-line immunotherapy in advanced kidney cancer, the impact of national cooperative group studies, and more.
The American Association for Cancer Research (AACR) Annual Meeting program covers the latest discoveries across the spectrum of cancer research — from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy — and highlights the work of the best minds in research and medicine from institutions all over the world.
Integrative Cancer Science — Global Impact — Individualized Patient Care
March 29 - April 3, 2019
Highlights included presentations on immunotherapy for solid tumors and updates on progress toward targeting the molecular drivers of lung, breast and prostate cancers.
The American Society of Hematology (ASH) is the worlds' largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. The ASH annual meeting provides is an educational experience providing the opportunity to review thousands of scientific abstracts on the hottest topics in hematology.
December 1-4, 2018
San Diego, CA
Fred Hutch researchers presented 50 talks and posters on a number of topics including cellular immunotherapies for leukemia, lymphoma and myeloma; gene therapy for hemoglobinopathies; hematopoietic cell transplantation; immune regeneration; and precision medicine for blood cancers.
A talk by the Hutch’s Dr. Jordan Gauthier on CAR T-cell combination therapy for leukemia will be featured in the ASH press program. The briefing, “CAR T-Cell Therapies: New Research and Updates from Pivotal Trials."